alexa
Reach Us +44-7482-864460
Reviewer - Yinan Zhang | Harvard University | 254
ISSN: 1747-0862

Journal of Molecular and Genetic Medicine
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Share This Page

Yinan Zhang

Yinan Zhang
Dept. of Genetics and Complex Diseases
Harvard University, School of Public Health

Biography

Dr Yinan Zhang has received his PhD in the University  of Toronto in 2009. Currently, he is working as research fellow in Harvard University. His research aims at identifying metabolic and stress response pathways that provide the most attractive intervention points for treating cancer.  Armed with such knowledge, he is trying to target these pathways by screening chemical compounds in search of new classes of cancer therapeutics. Based on this research and fellowship training he has received several awards and honors, such as: OGS Scholarship and Bradley Pett Award. He is serving as an editorial member of several reputed journals like Scigmoid Publications & expert Reviewers for journals like Current Cancer Drug Targets, Journal of Molecular and Genetic Medicine, and Cell Biology - Research & Therapy. He has authored several research articles/books. He is a member of American Academy of Arts and Sciences.

Research Interest

Cancer cells are dramatically different from normal cells in their metabolic functions. Yinan’s research aims at identifying metabolic and stress response pathways that provide the most attractive intervention points for treating cancer.  Armed with such knowledge, he is trying to target these pathways by screening chemical compounds in search of new classes of cancer therapeutics.
 
 

Global Speakers in the subject

Global Experts in the subject

Top